Amaran Biotech to participate BIO Asia-Taiwan 2023

BIO Asia–Taiwan 2023, an international gathering jointly organized by the global Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan BIO); will be held from July 27th to 30th at the Taipei Nangang Exhibition Center, Hall 1 (TaiNEX 1).

Amaran Biotech to participate BIO International Convention 2023

The world's largest biotechnology industry event "BIO International Convention 2023" will be held at the Boston Convention & Exhibition Center on June 5-8. Amaran Biotech, is invited by the Biotechnology and Pharmaceutical Industries Promotion Office, Ministry of Economic Affairs (BPIPO, MOEA) and the Taiwan External Trade Development Council (TAITRA), will jointly exhibit at the "Taiwan Pavilion".

【CLEANROOM TECHNOLOGY】Amaran Biotechnology installs first gloveless isolator of its kind in Taiwan

【The Korea Herald】Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31

【BioSpectrum Asia】Amaran Biotech introduces first fully-automated robotic aseptic filling line in Taiwan

【Outsourced Pharma】Amaran Biotech Introduces The First Fully-Automated Robotic Aseptic Filling Line In Taiwan During Bio Asia-Taiwan 2022 7/28-7/31

Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31

Amaran Biotechnology Inc., a subsidiary of Taiwan’s OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first in Taiwan, has been completed. The new facility minimizes the risks of human factors affecting the quality of the pharmaceutical products, and substantially enhances their safety. The project is now entering the final process validation phase of the medium fill procedures.

【Labiotech】First aseptic filling line and facilities completed in Taiwan

Amaran Biotech and OBI Pharma share exchange plan to form a strong synergistic cooperation

The Board of Directors of Amaran Biotechnology, Inc. passed a resolution on September 28th to exchange 67 percent of the Company’s shares with OBI Pharma, Inc. The share exchange transaction will be 53,466,000 shares of Amaran Biotech’s common stock in exchange for 10,693,200 shares of OBI Pharma’s common stock. OBI Pharma intends to issue new shares and increase capital in this transaction.

Interview Chairperson & GM, Amaran Biotech by Pharmaboardroom

Tessie Che, chairperson & GM of Amaran Biotech shares the story of how she came to lead the company and set its course to become a leading specialty biopharma CMO that leverages high-quality products and best manufacturing practices above all else. As a veteran in the life sciences and pharma industries, Che also shares her insights on the major trends shaping biopharma in Taiwan and internationally. Finally, Che concludes with a message about Amaran’s ambitions to set the gold standard for Taiwanese drug production.

Amaran Biotech to attend the Company Presentation session of BioAsia-Taiwan 2019

BioAsia-Taiwan 2019 will take place in the Taipei Nangang Exhibition Center and CTBC Financial Park on July 24 to July 28. BioTaiwan has established itself as one of the largest annual biotech events in Asia for the past 16 years. The Biotechnology Innovation Organization (BIO) and the Taiwan Bio Industry Organization (Taiwan Bio) have come together to present BioAsia-Taiwan. This year’s event themed “Biotech as the Next Growth Engine for Asia" will attract more than 1,500 attendees from 25 countries.

Amaran Biotech to participate INTERPHEX JAPAN 2019

INTERPHEX JAPAN 2019, Japan’s largest and Asia’s leading exhibition for pharmaceutical manufacturing and packaging technologies, will take place in Tokyo Big Sight on July 3 to July 5. INTERPHEX Week Japan consists of 4 exhibitions for pharmaceutical technologies, INTERPHEX JAPAN, in-Pharma Japan, BioPharma Expo and PharmaLab Japan. There will be over 1,280 exhibitors and visitors from all over Asia at this event.